Left atrial reservoir strain as a novel echocardiographic marker of diastolic dysfunction and mortality risk in sickle cell cardiomyopathy

Z Zineb Sadraoui (1CHU Henri Mondor, Physiology, Créteil, France) S Sihem Iles (1CHU Henri Mondor, Physiology, Créteil, France) L Lara Alassaad (1CHU Henri Mondor, Physiology, Créteil, France) C Camilia Regragui (1CHU Henri Mondor, Physiology, Créteil, France) G Gonzalo De Luna (4Coordinating Referral Center for Sickle Cell Disease and Red Blood Cell Disorders, Univ Paris Est Créteil, Hôpitaux Universitaires Henri Mondor, APHP, – UMGGR, Creteil, France) L Laurent Savale (INSERM, UMR_S 999, Pulmonary Hypertension: Pathophysiology and Novel Therapies (HPPIT)) H Haytham Derbel (4CHU Henri Mondor, Radiology, Créteil, France) M Michel Zeitouni (Institut de Cardiologie, AP-HP – Sorbonne Université, Hôpital Pitié-Salpêtrière, ACTION Group, Paris, France (M.Z., N.P., P. Guedeney, K.A).) Y Yosr Zaouali (2Sickle Cell Referral Center, Créteil, France) A Anoosha Habibi A Anne-Laure Pham Hung D'Alexandry D'Orengiani (2Sickle Cell Referral Center, Créteil, France) G Geneviève Derumeaux (1CHU Henri Mondor, Physiology, Créteil, France) L Laurent Boyer V Vincent De Pierrefeu (3Coordinating Referral Center for Sickle Cell Disease and Red Blood Cell Disorders – UMGGR, Univ Paris Est Créteil, Hôpitaux Universitaires Henri Mondor, APHP, Créteil, France Créteil, France, CRETEIL, France) P Pablo Bartolucci T Thomas d'Humieres (4Mondor University Hospital, APHP, Physiology, CRETEIL, France)

Abstract

Abstract Background: Cardiac involvement is a leading contributor to premature mortality in sickle cell disease (SCD), yet the diagnosis of diastolic dysfunction (DD) remains challenging in this population. Conventional echocardiographic markers—such as tricuspid regurgitation velocity (TRV) or left atrial volume (LAV) often lack sensitivity or are confounded by anemia-driven hemodynamic adaptations. Left atrial reservoir strain (LA-SR), a preload-sensitive marker of left ventricular filling pressure, has emerged as a reliable surrogate of DD in heart failure, but has never been evaluated in SCD. Methods: We prospectively studied 150 adults with SS or Sβ⁰-thalassemia enrolled in the DREPACOEUR cohort, a multicenter initiative aimed at phenotyping sickle cell cardiomyopathy. All patients were in steady state and underwent comprehensive transthoracic echocardiography, including speckle-tracking imaging to quantify LA-SR (Figure). LA-SR was compared with LAV and correlated with conventional DD markers (lateral E'<11 cm/s, NT-proBNP>160 ng/L and TRV), renal function, hemolysis parameters, and hemoglobin concentration [Hb]. Prognostic performance was evaluated using ROC analysis and Cox regression. Results: Mean age was 44 ± 12 years; 51% were female and 82% received hydroxyurea. LA-SR correlated more strongly with diastolic function than LAV, including NT-proBNP (r = –0.51, p<0.001), E' lat (r = –0.48, p<0.001), and eGFR (r = 0.44, p<0.001). Unlike LAV (r = –0.34, p<0.001), LA-SR was independent of hemoglobin levels, suggesting greater specificity for true diastolic impairment. An LA-SR threshold <26% identified patients with elevated NT-proBNP (AUC = 0.77) and impaired relaxation (E'<11 cm/s, AUC = 0.73), with sensitivity/specificity between 65–80%. Patients with LA-SR <26% were older (50 ± 10 vs. 39 ± 12 years, p<0.001), with more advanced DD (E/E' = 8.7 ± 3.2 vs. 6.6 ± 2.2, p<0.001), higher TRV and LAV, and worse renal function. They also displayed more frequent atrial and ventricular ectopy. During a median 3.3 ± 1.2 years of follow-up, a LA-SR<26% was independently associated with all-cause mortality (OR=7, p=0.006), unlike TRV or LAV in this population. Conclusions: Left atrial reservoir strain offers incremental diagnostic and prognostic value over conventional echocardiographic parameters in sickle cell cardiomyopathy. Unlike LAV, which reflects both anemia and diastolic burden, LA-SR is not influenced by hemoglobin concentration, making it a specific and robust marker of DD. An LA-SR <26% identifies patients with early ventricular dysfunction and higher mortality risk, supporting its integration into routine SCD echocardiographic evaluation.

Article Details

Journal Blood
Volume / Issue Vol. 146, Issue Supplement 1
Published November 03, 2025
Pages 296-296
ISSN 0006-4971
Publisher Elsevier BV

Journal Info

Blood

Elsevier BV

ISSN: 0006-4971 Health Sciences

Authors (16)

Z

Zineb Sadraoui

1CHU Henri Mondor, Physiology, Créteil, France

S

Sihem Iles

1CHU Henri Mondor, Physiology, Créteil, France

L

Lara Alassaad

1CHU Henri Mondor, Physiology, Créteil, France

C

Camilia Regragui

1CHU Henri Mondor, Physiology, Créteil, France

G

Gonzalo De Luna

4Coordinating Referral Center for Sickle Cell Disease and Red Blood Cell Disorders, Univ Paris Est Créteil, Hôpitaux Universitaires Henri Mondor, APHP, – UMGGR, Creteil, France

L

Laurent Savale

INSERM, UMR_S 999, Pulmonary Hypertension: Pathophysiology and Novel Therapies (HPPIT)

H

Haytham Derbel

4CHU Henri Mondor, Radiology, Créteil, France

M

Michel Zeitouni

Institut de Cardiologie, AP-HP – Sorbonne Université, Hôpital Pitié-Salpêtrière, ACTION Group, Paris, France (M.Z., N.P., P. Guedeney, K.A).

Y

Yosr Zaouali

2Sickle Cell Referral Center, Créteil, France

A

Anoosha Habibi

A

Anne-Laure Pham Hung D'Alexandry D'Orengiani

2Sickle Cell Referral Center, Créteil, France

G

Geneviève Derumeaux

1CHU Henri Mondor, Physiology, Créteil, France

L

Laurent Boyer

V

Vincent De Pierrefeu

3Coordinating Referral Center for Sickle Cell Disease and Red Blood Cell Disorders – UMGGR, Univ Paris Est Créteil, Hôpitaux Universitaires Henri Mondor, APHP, Créteil, France Créteil, France, CRETEIL, France

P

Pablo Bartolucci

T

Thomas d'Humieres

4Mondor University Hospital, APHP, Physiology, CRETEIL, France